Literature DB >> 23045598

Running on empty: cardiovascular reserve capacity and late effects of therapy in cancer survivorship.

Graeme J Koelwyn1, Michel Khouri, John R Mackey, Pamela S Douglas, Lee W Jones.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23045598      PMCID： PMC3518726          DOI： 10.1200/JCO.2012.44.0891

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  55 in total

Review 1.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease.

Authors:  Edward G Lakatta; Daniel Levy
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

2.  Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study.

Authors:  Emily Ho; Angela Brown; Patrick Barrett; Roisin B Morgan; Gerard King; M John Kennedy; Ross T Murphy
Journal:  Heart       Date:  2010-05       Impact factor: 5.994

3.  Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity.

Authors:  Michael S Ewer; Scott M Lippman
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

4.  Cardiotoxicity of trastuzumab in clinical practice.

Authors:  Heather L McArthur; Stephen Chia
Journal:  N Engl J Med       Date:  2007-07-05       Impact factor: 91.245

5.  A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin.

Authors:  M S Ewer; M K Ali; B Mackay; S Wallace; M Valdivieso; S S Legha; R S Benjamin; T P Haynie
Journal:  J Clin Oncol       Date:  1984-02       Impact factor: 44.544

6.  Adjuvant trastuzumab in HER2-positive breast cancer.

Authors:  Dennis Slamon; Wolfgang Eiermann; Nicholas Robert; Tadeusz Pienkowski; Miguel Martin; Michael Press; John Mackey; John Glaspy; Arlene Chan; Marek Pawlicki; Tamas Pinter; Vicente Valero; Mei-Ching Liu; Guido Sauter; Gunter von Minckwitz; Frances Visco; Valerie Bee; Marc Buyse; Belguendouz Bendahmane; Isabelle Tabah-Fisch; Mary-Ann Lindsay; Alessandro Riva; John Crown
Journal:  N Engl J Med       Date:  2011-10-06       Impact factor: 91.245

7.  Natural history of asymptomatic left ventricular systolic dysfunction in the community.

Authors:  Thomas J Wang; Jane C Evans; Emelia J Benjamin; Daniel Levy; Elizabeth C LeRoy; Ramachandran S Vasan
Journal:  Circulation       Date:  2003-08-11       Impact factor: 29.690

8.  Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.

Authors:  M Baum; A U Budzar; J Cuzick; J Forbes; J H Houghton; J G M Klijn; T Sahmoud
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

9.  Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.

Authors:  R Peto; C Davies; J Godwin; R Gray; H C Pan; M Clarke; D Cutter; S Darby; P McGale; C Taylor; Y C Wang; J Bergh; A Di Leo; K Albain; S Swain; M Piccart; K Pritchard
Journal:  Lancet       Date:  2011-12-05       Impact factor: 79.321

10.  Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study.

Authors:  Jennifer L Patnaik; Tim Byers; Carolyn DiGuiseppi; Dana Dabelea; Thomas D Denberg
Journal:  Breast Cancer Res       Date:  2011-06-20       Impact factor: 6.466
View more
  26 in total

1.  Cardiovascular Function in Long-Term Hematopoietic Cell Transplantation Survivors.

Authors:  Saro H Armenian; David Horak; Jessica M Scott; George Mills; Aida Siyahian; Jennifer Berano Teh; Pamela S Douglas; Stephen J Forman; Smita Bhatia; Lee W Jones
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-05       Impact factor: 5.742

2.  Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study.

Authors:  C R Kelsey; J M Scott; A Lane; E Schwitzer; M J West; S Thomas; J E Herndon; M G Michalski; M E Horwitz; T Hennig; L W Jones
Journal:  Bone Marrow Transplant       Date:  2014-07-28       Impact factor: 5.483

3.  Exercise and risk of major cardiovascular events in adult survivors of childhood hodgkin lymphoma: a report from the childhood cancer survivor study.

Authors:  Lee W Jones; Qi Liu; Gregory T Armstrong; Kirsten K Ness; Yutaka Yasui; Katie Devine; Emily Tonorezos; Luisa Soares-Miranda; Charles A Sklar; Pamela S Douglas; Leslie L Robison; Kevin C Oeffinger
Journal:  J Clin Oncol       Date:  2014-10-13       Impact factor: 44.544

Review 4.  Treatment-related cardiovascular late effects and exercise training countermeasures in testicular germ cell cancer survivorship.

Authors:  Jesper F Christensen; Mikkel Bandak; Anna Campbell; Lee W Jones; Pernille Højman
Journal:  Acta Oncol       Date:  2015-03-09       Impact factor: 4.089

Review 5.  Exercise Therapy and Cardiovascular Toxicity in Cancer.

Authors:  Jessica M Scott; Tormod S Nilsen; Dipti Gupta; Lee W Jones
Journal:  Circulation       Date:  2018-03-13       Impact factor: 29.690

6.  Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy.

Authors:  Michel G Khouri; Whitney E Hornsby; Niels Risum; Eric J Velazquez; Samantha Thomas; Amy Lane; Jessica M Scott; Graeme J Koelwyn; James E Herndon; John R Mackey; Pamela S Douglas; Lee W Jones
Journal:  Breast Cancer Res Treat       Date:  2014-01-04       Impact factor: 4.872

7.  Adolescents and young adult cancer survivors: exercise habits, quality of life and physical activity preferences.

Authors:  A Murnane; K Gough; K Thompson; L Holland; R Conyers
Journal:  Support Care Cancer       Date:  2014-10-08       Impact factor: 3.603

8.  Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Crystal S Denlinger; Tara Sanft; K Scott Baker; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Allison King; Divya Koura; Robin M Lally; Terry S Langbaum; Allison L McDonough; Michelle Melisko; Jose G Montoya; Kathi Mooney; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; William Pirl; M Alma Rodriguez; Kathryn J Ruddy; Paula Silverman; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2018-10       Impact factor: 11.908

Review 9.  Cardiovascular Late Effects and Exercise Treatment in Breast Cancer: Current Evidence and Future Directions.

Authors:  Jessica M Scott; Scott C Adams; Graeme J Koelwyn; Lee W Jones
Journal:  Can J Cardiol       Date:  2016-04-01       Impact factor: 5.223

10.  Safety and efficacy of aerobic training in patients with cancer who have heart failure: an analysis of the HF-ACTION randomized trial.

Authors:  Lee W Jones; Pamela S Douglas; Michel G Khouri; John R Mackey; Daniel Wojdyla; William E Kraus; David J Whellan; Christopher M O'Connor
Journal:  J Clin Oncol       Date:  2014-07-07       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.